Acquirer Profile
Merck Acquisitions & Deals (2026)
oncology · Healthcare
Deals tracked
6
Combined value
$13.4B
Primary sector
oncology
Active
2026
FireStrike tracks every Merck acquisition, merger, and strategic investment in real time. This page covers 6 Merck deals totaling $13.4B in disclosed deal value, spanning oncology, Healthcare. Data covers 2026.
Merck Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Revolution Medicines Biotechnology | Jan 2026 | |
Cidara Therapeutics Biotechnology | Feb 2026 | |
Cidara Pharmaceuticals | Feb 2026 | |
Terns Pharmaceuticals oncology | May 2026 | |
Terns Pharma Healthcare | Mar 2026 | |
Eikon Therapeutics Professional, Scientific, and Technical Services (541) | Jan 2026 |
Merck Acquisitions — FAQ
How many acquisitions has Merck made?
Merck has made 6 acquisitions and deals tracked on FireStrike, totaling $13.4B in combined deal value.
What sectors does Merck acquire in?
Merck primarily acquires in oncology, Healthcare.
What is Merck's most recent acquisition?
Merck's most recent tracked acquisition is Revolution Medicines for $30B, announced Jan 2026.
Get every Merck deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →